This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.

3rd Next-Generation Conjugates Summit

151 151 people viewed this event.

Driving Innovation in Discovery and Chemistry, Validating Clinical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads and Formats
Traditional ADCs have seen significant success in recent years, but still face many challenges, from limited payload capacities to significant toxicities.

Given these limitations, drug developers are venturing beyond the conventional boundaries of conjugate drug design, by exploring novel payloads and targeting formats, with companies including VincerX Pharma, Dyne Therapeutics, and Orum Therapeutics currently awaiting clinical validation.

 

Time: 8:30 AM – 5:00 PM

Venue details: Hotel Commonwealth, 500 Commonwealth Avenue, Boston, Massachusetts, 02215, United States

Prices: USD 2599.00 – USD 5097.00

Speakers: Amy Han, Executive Director, R AND D Chemistry, Regeneron, Bin Wu, Principal Scientist, Amgen Inc., and more

Event Organizer - Hanson Wade

Event Website
 

Date

26–28 February 2024
 

City

 

Country

United States of America
 

Topic Area

Health and Medicine

Share With Colleagues